Rebodis Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Rebodis Inc. - overview
Established
2025
Location
Seoul, -, South Korea
Primary Industry
Medical Devices & Equipment
About
Rebodis Inc. , based in South Korea, specializes in creating advanced AI-driven wearable robotic solutions aimed at enhancing individual mobility and quality of life through innovative technology. Founded in 2025, Rebodis Inc. is dedicated to developing wearable robots that improve mobility for individuals facing physical challenges.
The company is headquartered in Seoul, South Korea. The founding team includes Kyu-jin Cho and Sung-sik Yun, who serve as the CEO. Rebodis has completed one investment deal to date, raising KRW 500 million in Seed funding from Bass Ventures on January 7, 2026, which represents the total amount raised by the company. Rebodis specializes in innovative wearable robot technology that enhances the quality of life for users by offering intelligent clothing solutions.
Their flagship products feature soft wearable robots that combine advanced robotics with a human-centered design for improved mobility. Utilizing soft robotics technology, these products are made from flexible materials for everyday comfort and usability. The company targets a diverse clientele, especially individuals of all ages who have mobility limitations due to aging or disabilities. Rebodis primarily aims to introduce its solutions in South Korea, Japan, and the United States, addressing the growing demand for assistive technologies.
Rebodis generates revenue through direct-to-consumer sales and B2B partnerships, focusing on healthcare and assistive technology sectors. Their business model involves selling flagship products directly to end-users, including healthcare providers, which emphasizes mobility enhancement. Pricing reflects the advanced technology and customization of their products, with possible subscription-based services for ongoing support. Partnering with rehabilitation centers and clinics further facilitates revenue by enabling these institutions to provide innovative solutions for their patients.
Rebodis Inc. plans to leverage the KRW 500 million raised in Seed funding to enhance its development capabilities, focusing on advancing product innovation and expanding production capacity. The company is also working on new product designs that will be launched in the near future. Moreover, Rebodis aims to expand its market reach into new geographic regions, specifically targeting markets in Japan and the United States by the end of 2026.
Current Investors
Bass Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Clothing, Therapeutic Devices
Website
www.rebodis.com/
Verticals
Artificial Intelligence, Mobile Apps, Robotics
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.